SEC Form 4 · accession 0001739481-18-000018
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry F Connick Sr.
Director
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 3:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | May 3, 2018 | A | 3,400 | $0.00 | A | 52,562 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units that are to be settled solely in shares of Common Stock. The units vest with respect to 50% of the shares on April 30, 2019 and with respect to the remaining 50% on April 30, 2020, so long as the recipient continues as a director of the Issuer through each such respective vesting date.